Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1966 1
1968 1
1974 1
1977 2
1979 1
1980 2
1981 7
1982 4
1984 2
1986 3
1987 1
1988 2
1989 7
1990 4
1991 7
1992 4
1993 4
1994 8
1995 12
1996 8
1997 10
1998 15
1999 2
2000 6
2001 4
2002 7
2003 5
2004 2
2005 3
2006 7
2007 4
2008 5
2009 7
2010 7
2011 4
2012 9
2013 8
2014 9
2015 8
2016 7
2017 4
2018 10
2019 6
2020 9
2021 10
2022 5
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Antiviral effect of electrolyzed reduced water on SARS-CoV-2.
Okajima Y, Okajima M, Ikeda M, Wada Y, Shimokawa KI, Ishii F. Okajima Y, et al. Drug Discov Ther. 2021 Nov 21;15(5):268-272. doi: 10.5582/ddt.2021.01092. Epub 2021 Oct 28. Drug Discov Ther. 2021. PMID: 34707021 Free article.
[Personality disorder].
Okajima Y. Okajima Y. Nihon Rinsho. 2007 Mar;65(3):502-5. Nihon Rinsho. 2007. PMID: 17354566 Review. Japanese.
Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T, Kuba M, Koyasu S, Yamamoto Y, Motomura K, Arulmozhiraja S, Ohno H, Sharma R, Shimura T, Okajima Y, Han SI, Aita Y, Mizunoe Y, Osaki Y, Iwasaki H, Yatoh S, Suzuki H, Sone H, Takeuchi Y, Yahagi N, Miyamoto T, Sekiya M, Nakagawa Y, Ema M, Takahashi S, Tokiwa H, Shimano H. Matsuzaka T, et al. Among authors: okajima y. Hepatology. 2020 May;71(5):1609-1625. doi: 10.1002/hep.30953. Epub 2020 Feb 7. Hepatology. 2020. PMID: 31529722
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
Hamada H, Suzuki H, Onouchi Y, Ebata R, Terai M, Fuse S, Okajima Y, Kurotobi S, Hirai K, Soga T, Ishiguchi Y, Okuma Y, Takada N, Yanai M, Sato J, Nakayashiro M, Ayusawa M, Yamamoto E, Nomura Y, Hashimura Y, Ouchi K, Masuda H, Takatsuki S, Hirono K, Ariga T, Higaki T, Otsuki A, Terauchi M, Aoyagi R, Sato T, Fujii Y, Fujiwara T, Hanaoka H, Hata A; KAICA trial Investigators. Hamada H, et al. Among authors: okajima y. Lancet. 2019 Mar 16;393(10176):1128-1137. doi: 10.1016/S0140-6736(18)32003-8. Epub 2019 Mar 7. Lancet. 2019. PMID: 30853151 Clinical Trial.
Identification of key microRNAs regulating ELOVL6 and glioblastoma tumorigenesis.
Istiqamah N, Matsuzaka T, Shimizu M, Motomura K, Ohno H, Hasebe S, Sharma R, Okajima Y, Matsuda E, Han SI, Mizunoe Y, Osaki Y, Aita Y, Suzuki H, Sone H, Takeuchi Y, Sekiya M, Yahagi N, Nakagawa Y, Shimano H. Istiqamah N, et al. Among authors: okajima y. BBA Adv. 2023 Jan 22;3:100078. doi: 10.1016/j.bbadva.2023.100078. eCollection 2023. BBA Adv. 2023. PMID: 37082255 Free PMC article.
Authors' reply to Phan and Hui.
Arai Y, Okajima Y, Kotani K, Tamba K. Arai Y, et al. Among authors: okajima y. J Pain Symptom Manage. 2014 Jan;47(1):e6-7. doi: 10.1016/j.jpainsymman.2013.10.008. Epub 2013 Dec 2. J Pain Symptom Manage. 2014. PMID: 24291295 Free article. No abstract available.
248 results